A broad-spectrum antibiofilm peptide enhances antibiotic action against bacterial biofilms. - Test2 - elhamkhani - TriplyDB

A broad-spectrum antibiofilm peptide enhances antibiotic action against bacterial biofilms.

A broad-spectrum antibiofilm peptide enhances antibiotic action against bacterial biofilms.

http://www.wikidata.org/entity/Q34057449

about

Anti-biofilm Activity as a Health Issue The Three Bacterial Lines of Defense against Antimicrobial Agents Antibiotic adjuvants: diverse strategies for controlling drug-resistant pathogens.Staphylococcus aureus biofilms: recent developments in biofilm dispersal.D-enantiomeric peptides that eradicate wild-type and multidrug-resistant biofilms and protect against lethal Pseudomonas aeruginosa infections Antibiofilm peptides increase the susceptibility of carbapenemase-producing Klebsiella pneumoniae clinical isolates to β-lactam antibiotics.Targets for Combating the Evolution of Acquired Antibiotic Resistance Anti-Biofilm and Immunomodulatory Activities of Peptides That Inhibit Biofilms Formed by Pathogens Isolated from Cystic Fibrosis Patients.Immunomodulatory Peptide IDR-1018 Decreases Implant Infection and Preserves Osseointegration.Cationic bactericidal peptide 1018 does not specifically target the stringent response alarmone (p)ppGpp Characterization of Multi-Drug Resistant Enterococcus faecalis Isolated from Cephalic Recording Chambers in Research Macaques (Macaca spp.).Membrane-permeabilizing activity of reverse-amide 2-aminoimidazole antibiofilm agents against Acinetobacter baumannii.Peptide modification results in the formation of a dimer with a 60-fold enhanced antimicrobial activity Using anti-biofilm peptides to treat antibiotic-resistant bacterial infections.Synergistic Nisin-Polymyxin Combinations for the Control of Pseudomonas Biofilm Formation.An anti-infective synthetic peptide with dual antimicrobial and immunomodulatory activities.Synergistic effects of antimicrobial peptide DP7 combined with antibiotics against multidrug-resistant bacteria.Peptide IDR-1018: modulating the immune system and targeting bacterial biofilms to treat antibiotic-resistant bacterial infections.Many means to a common end: the intricacies of (p)ppGpp metabolism and its control of bacterial homeostasis.Synthetic antibiofilm peptides.Engineered cationic antimicrobial peptide (eCAP) prevents Pseudomonas aeruginosa biofilm growth on airway epithelial cells CRISPR-Cas9 technology: applications in genome engineering, development of sequence-specific antimicrobials, and future prospects.Potential of a lytic bacteriophage to disrupt Acinetobacter baumannii biofilms in vitro.New molecules and adjuvants in the treatment of infections by Acinetobacter baumannii.Antibiofilm Peptides: Potential as Broad-Spectrum Agents Anti-biofilm peptides as a new weapon in antimicrobial warfare.An Immunomodulatory Peptide Confers Protection in an Experimental Candidemia Murine Model.Strategies for combating bacterial biofilms: A focus on anti-biofilm agents and their mechanisms of action.Biofilm dispersal: multiple elaborate strategies for dissemination of bacteria with unique properties.Strategies for Biofilm Inhibition and Virulence Attenuation of Foodborne Pathogen-Escherichia coli O157:H7.Inactivation of Acinetobacter baumannii Biofilms on Polystyrene, Stainless Steel, and Urinary Catheters by Octenidine Dihydrochloride.Repurposing of nucleoside- and nucleobase-derivative drugs as antibiotics and biofilm inhibitors.The efficacy of different anti-microbial metals at preventing the formation of, and eradicating bacterial biofilms of pathogenic indicator strains.Subinhibitory Concentrations of Bacteriostatic Antibiotics Induce relA-Dependent and relA-Independent Tolerance to β-Lactams.Challenges and Opportunities of Nontraditional Approaches to Treating Bacterial Infections.Synthetic Peptides to Target Stringent Response-Controlled Virulence in a Pseudomonas aeruginosa Murine Cutaneous Infection Model.Synthetic host defense peptide IDR-1002 reduces inflammation in Pseudomonas aeruginosa lung infection.Antimicrobial Peptides: An Introduction.Use of Calgary and Microfluidic BioFlux Systems To Test the Activity of Fosfomycin and Tobramycin Alone and in Combination against Cystic Fibrosis Pseudomonas aeruginosa Biofilms.Computer-aided Discovery of Peptides that Specifically Attack Bacterial Biofilms.

P2860

Q26747450-0A556350-40FE-4D26-92F9-AF865A83D1F8 Q26786956-259BFF87-6696-464F-8F29-91644D78F5C5 Q34447679-6A0767DB-DD45-4719-800B-1E050A968875 Q34763740-53DF19F7-D48D-4435-B582-2BBFF3217681 Q35185982-77C89707-07F1-4BF7-B663-6EA965D1EF29 Q35746171-DD61307C-744E-43CC-9E4F-5DDF57B7FD30 Q35754447-1B2EBCD9-4076-41F2-A276-8338DEC3EC76 Q35890186-5B6BABE9-7D91-4635-B6A5-76B9A8B1F2E3 Q35912382-B2AA4102-4B84-40F4-9DF6-CDC491628954 Q36183973-9B522E8B-F8B7-4953-93DF-9637FB6C41B9 Q36247470-824E0165-DDC4-40D9-92E1-E5ED8D16359A Q36267035-9F0D70FD-5E78-4446-B525-72BE3CC88E8F Q36309109-EB3B471E-D694-4809-9AA2-6241EBB6E101 Q37197790-65C103C8-F9DA-4931-BD80-024714A25C68 Q37366258-250CB301-EAB8-4952-B665-8BA7566F68CC Q37386135-6A834F36-2F41-4777-AF07-5DDE74F76E87 Q37722952-16ACC222-0478-4339-BADC-7B1C6971B0DE Q38263995-C180AEDA-E48F-482E-A294-5DB446DC035F Q38326030-AB7ECD79-E3DD-4A0B-BCA6-0271C07C5871 Q38685066-038D3D81-232D-4E29-96E7-F2E8C6EE79D7 Q38768190-2FEB17E9-EA62-43C7-824D-83A6B7079261 Q38775349-CFEA50F7-70B5-452A-8265-B58800F0DE0D Q38803930-F1F10D76-FA3C-44E0-B079-B47F99A3935E Q38805100-00C872CC-869B-4B72-A3D2-8F723D6AAC9D Q38805599-197C0D54-4D15-409C-B4B4-1F2469640C1F Q38869269-D528AE81-732F-4611-BDB1-6DF8121BB176 Q39011788-68225E39-7411-413C-91B2-8022F7259168 Q39210862-5A9B9CC0-5DF8-4AD7-990E-61B6BF6C7EAD Q39250412-2177A01E-99DC-44C9-A24A-CA088279B1D2 Q39458640-67807101-C182-4F19-A88C-CE9D33B3B3F6 Q39634407-311D7C84-B616-455A-ABAF-90D6CC3B0EB0 Q40187481-985BFB53-09B6-40FF-8C05-F9E2B198447E Q40333304-828AD620-BD16-42CB-A56D-B85F8C4A5357 Q40361184-06847F4B-4AD5-4F5C-9009-DB06B2E96BD5 Q41859542-6F03DFFF-C4B7-47C8-B74E-590EFCF81956 Q41986754-7685A9D4-1C16-47BF-BAA5-61E1537F6B52 Q47118800-423F534E-A623-4911-813C-22C9FE567310 Q47375349-55201DF0-9A2A-49A5-BEA1-C2F607C7086C Q47398091-BF8152DD-0E87-4D36-91F1-27926C9676BC Q49571027-F892328A-85B8-47AA-965F-6D82FE9A5D03

P2860

A broad-spectrum antibiofilm peptide enhances antibiotic action against bacterial biofilms.

http://www.wikidata.org/entity/Q34057449

description

2014 nî lūn-bûn

@nan

2014 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

A broad-spectrum antibiofilm p ...... on against bacterial biofilms.

@ast

A broad-spectrum antibiofilm p ...... on against bacterial biofilms.

@en

A broad-spectrum antibiofilm p ...... on against bacterial biofilms.

@nl

type

label

A broad-spectrum antibiofilm p ...... on against bacterial biofilms.

@ast

A broad-spectrum antibiofilm p ...... on against bacterial biofilms.

@en

A broad-spectrum antibiofilm p ...... on against bacterial biofilms.

@nl

prefLabel

A broad-spectrum antibiofilm p ...... on against bacterial biofilms.

@ast

A broad-spectrum antibiofilm p ...... on against bacterial biofilms.

@en

A broad-spectrum antibiofilm p ...... on against bacterial biofilms.

@nl

P1433

Q34057449-26D6F3F3-CD4E-4DA7-88D4-9F329BE8526A

P1476

Q34057449-84E932AA-9A25-475D-98F9-38278B092D35

P2093

Q34057449-67FEF9F1-483F-4A65-92B5-356E2F3DB684

Q34057449-A6FA5179-AC65-4382-9AF9-93711DEDC43C

Q34057449-C6D3B589-00A6-46F3-BD82-D43F251F6050

P2860

Q34057449-057A9154-9A2C-4F68-AAFD-EEC8D73A0465

Q34057449-1604FF5B-3F22-4963-9D20-3ED5E62D08BC

Q34057449-1FE2697F-D586-4146-AA33-29F558D02AA9

Q34057449-24C17340-0741-47A8-9E3A-D99D0B6C77DB

Q34057449-70BBF1F4-090D-4D0E-8BED-33DF2641D70D

Q34057449-75A4F63D-6DF4-4F01-A942-4D2BA3177583

Q34057449-7FDE9ECD-5A6C-4887-9264-B29E6FAE0DFA

Q34057449-816F9647-3866-4818-B72E-A1B35511F24D

Q34057449-9B60A474-E9D1-4120-B528-3C766786DDC5

Q34057449-B5722870-CF8F-40E3-B279-05F49A430794

P304

Q34057449-CC22B14C-3E2D-4D2B-B448-C33F87749709

P31

Q34057449-F893D305-5769-45B2-AA26-F85185FA8018

P356

Q34057449-BBA3719F-F162-44AA-9F13-D64A236E8B8F

P407

Q34057449-4AA7F9F3-7BF8-40A0-8773-7376933C6EE7

P433

Q34057449-AB931202-587E-422A-B4D9-8C59BEB1929B

P478

Q34057449-F06ACF2C-FF7D-4A7B-8088-F1F26148F8BE

P50

Q34057449-94082969-4401-4A42-BDBF-98AF6EA75369

P577

Q34057449-C8C98214-EDBF-487F-ACAE-B6B9D350F847

P5875

Q34057449-FDE178B0-91CF-449B-84BE-975FCFF1A7ED

P698

Q34057449-D9FD9568-1568-4A25-9063-3852C3ADFB5B

P921

Q34057449-6857F217-AB86-43DC-B81B-6A19A825EC89

P932

Q34057449-AF3E020D-B447-4AD8-80DF-7D07AD2F8355

P356

P1433

Antimicrobial Agents and Chemotherapy

P1476

A broad-spectrum antibiofilm p ...... on against bacterial biofilms.

@en

P2093

César de la Fuente-Núñez

http://www.w3.org/2001/XMLSchema#string

Fany Reffuveille

http://www.w3.org/2001/XMLSchema#string

Sarah Mansour

http://www.w3.org/2001/XMLSchema#string

P2860

Bacterial biofilms: a common cause of persistent infections

Adaptive resistance to the "last hope" antibiotics polymyxin B and colistin in Pseudomonas aeruginosa is mediated by the novel two-component regulatory system ParR-ParS

Broad-spectrum anti-biofilm peptide that targets a cellular stress response

Bacterial biofilms: from the natural environment to infectious diseases

High rates of conjugation in bacterial biofilms as determined by quantitative in situ analysis.

Active starvation responses mediate antibiotic tolerance in biofilms and nutrient-limited bacteria

The pel polysaccharide can serve a structural and protective role in the biofilm matrix of Pseudomonas aeruginosa.

Role of the (p)ppGpp synthase RSH, a RelA/SpoT homolog, in stringent response and virulence of Staphylococcus aureus.

The clinical impact of bacterial biofilms.

Inhibition of bacterial biofilm formation and swarming motility by a small synthetic cationic peptide

P304

5363-5371

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/AAC.03163-14

http://www.w3.org/2001/XMLSchema#string

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

58

http://www.w3.org/2001/XMLSchema#string

P50

Robert E. W. Hancock

P577

2014-06-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

263706192

http://www.w3.org/2001/XMLSchema#string

P698

24982074

http://www.w3.org/2001/XMLSchema#string

P921

P932

4135845

http://www.w3.org/2001/XMLSchema#string